Sarah Romano, CFO at Kiora Pharmaceuticals, holds 18.01K shares in Entero Therapeutics (Ticker: ENTO), holds 22.75K shares in Kiora Pharmaceuticals (Ticker: KPRX). Most recently, Sarah Romano Sold ― shares of Entero Therapeutics on Oct 10, 2024 for an estimated value of 209.44.
What is the percentage of profitable transactions made by Sarah Romano?
The percentage of profitable transactions made by Sarah Romano is 70%.
What is the average return per transaction made by Sarah Romano?
The average return per transaction made by Sarah Romano is 40.40%.
What stocks does Sarah Romano hold?
Sarah Romano holds: KPRX, ENTO stocks.
What was Sarah Romano’s latest transaction?
Sarah Romano latest transaction was an Informative Sell of $209.44.
What was Sarah Romano's most profitable transaction?
Sarah Romano’s most profitable transaction was an Informative Sell of ENTO stock on July 5, 2023. The return on the trade was 96.40%.
What is Sarah Romano's role in Kiora Pharmaceuticals?
Sarah Romano's role in Kiora Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.